Familial Hypertrophic Cardiomyopathy

1

Review clinical trials related to Familial Hypertrophic Cardiomyopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository

The Hearts in Rhythm Organization (HiRO) is a national network of Canadian researchers/clinicians, working towards a better understanding of the rare genetic causes of sudden cardiac death (SCD). The HiRO Hypertrophic Cardiomyopathy registry, biobank and imaging data repository (HiRO-HCM) is a multicenter study that will prospectively enroll patients with HCM as well as those carrying sarcomeric gene variants predisposing to HCM. The objectives of HiRO-HCM are: 1. to better understand the natural history of the disease and identify clinical markers and biomarkers for adverse outcomes; 2. to derive and validate risk prediction models for disease expression, complications and response to therapy; 3. to better define the genetic architecture of sarcomeric and non-sarcomeric HCM.

Participants needed: 2,000
Trial details
Biological sex: AllType: ObservationalSponsor: Montreal Heart InstituteUpdated: Oct 9, 2026Locations: 17Duration: 5 Years
Eligibility criteria

Clinical diagnosis of HCM, defined as [+4]

Clinical or molecular diagnosis of Noonan syndrome or other Rasopathies [+11]